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ABSTRACT 
Objective: To investigate the in vitro oxidant scavenging properties of rottlerin and to study the potential role of rottlerin on ethylene glycol 
induced nephrocalcinosis in rats. 
Methods: In vitro oxidant scavenging properties of rottlerin were studied along with its effect on in vitro calcium phosphate mineralization. For the 
in vivo studies, hyperoxaluria was induced by administering 0.4 % ethylene glycol and 1 % ammonium chloride in drinking water to male wistar 
rats for 9 d. Rottlerin was administered intraperitoneally at 1mg/kg/d along with the hyperoxaluric agent. Total thiols content, activities of 
glutathione-S-transferase (GST), glutathione reductase (GR), Citrate synthase (CS), isocitrate dehydrogenase (ICDH), ATPase and urinary 
parameters were studied. 
Results: Rottlerin showed in vitro DPPH, superoxide, and ABTS radical scavenging activity along with inhibition of calcium phosphate 
mineralization in an in vitro homogeneous system. The diminished activities of GST, GR, ICDH, CS, ATPase and level of total thiols were considerably 
stabilized by rottlerin, suggesting that rottlerin provides protection against oxalate induced oxidative damage. 
Conclusion: We suggest that rottlerin protects the integrity of the renal cell by stabilizing the free-radical mediated damage. Thus, the present study 
reveals that the antioxidant nature of rottlerin protects the renal cells against oxalate-induced injury and thus, rottlerin may prevent against 
hyperoxaluria induced oxidative damage. 
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INTRODUCTION 
Hyperoxaluria is one of the major risk factors for calcium oxalate 
kidney stone formation in humans. Oxalate is normally excreted by 
the kidneys, however, increased urinary excretion of oxalate, can 
be toxic largely because of its propensity to crystallize at 
physiologic pH and form calcium oxalate crystal deposits in the 
kidneys [1]. In the kidneys, calcium oxalate crystals can block the 
renal tubules, disrupt cellular functions and kill nearby cells. 
Despite the major technical achievements for stone removal in the 
last three decades, the problem of recurrent stone formation 
remains. The recurrence rate of kidney stones is approximately 15 
% in the first year and as high as 50 % within 5 y of the initial 
stone [2].  
Oxalate and calcium oxalate crystals induced oxidative stress leads 
to renal injury and inflammation. Antioxidants vitamin E, catalase, 
deferoxamine, superoxide dismutase, and its mimetic provide 
protection from the generation of ROS and associated lipid 
peroxidation and injury. Citrate is also involved in maintaining 
endogenous antioxidant defenses [3]. 
Rottlerin, unlike other polyphenols, is not present in edible 
vegetables and in common beverages; instead, it is primarily 
present in the gland hair covering the fruit of Mallotus 
philippinensis (Euphorbiaceae), that is inedible and only used by 
indigenous populations of Southeast Asian tropical regions. 
Rottlerin is used as a dye for coloring textiles and as an old folk 
remedy against tapeworm (when taken orally) and scabies and 
ringworm (when applied topically) [4]. It Inhibits PKC-δ (IC50=3-
6µM), PKC-α, β, γ (IC50=30-42µM) and PKC ε, η (IC50=80-100 µM). 
It also inhibits p38 regulated activated protein kinase; MAPK 
activated protein kinase, JNKα1, cAMP-dependent protein kinase 
2, JNKα1, cAMP-dependent protein kinase, 3-phosphoinositide 
dependent protein kinase 1, protein kinase B-α, GSK-3-β along 
with non-kinase enzymes like β-lactamase, α-chymotrypsin and 
malate dehydrogenase [5]. 
Two molecules of DPPH are reduced by one molecule of rottlerin, 
indicating that rottlerin can donate two hydrogens from its five 
phenolic hydroxyl groups. The antioxidant properties of rottlerin 
have also been confirmed in cultured cells (MCF-7) [6-7]. Rottlerin 
exhibits anti-inflammatory properties by inhibiting arachidonic acid 
metabolism through some pathways, such as interference with PKC-
δ signaling, inhibition of NF-κB and STAT transcriptional activity, 
and/or direct binding to COX and LOX [5]. 
The supplementation of vitamin E, methionine, and lipoic acid was able 
to normalize the antioxidant status, leading to the prevention of renal 
injury and thereby associating a role for antioxidants in the 
pathophysiology of oxalate-mediated injury and calcium oxalate 
deposition [8-10]. These data maintain the notion that rottlerin may 
protect renal cells against injury induced by oxalate mediated oxidative 
stress. In the light of antioxidant and anti-inflammatory properties of 
rottlerin, the present study explored the effect of rottlerin on 
mineralization and hyperoxaluric manifestations in rats. To date, 
however, no study about this presumed effect has been reported. 
MATERIALS AND METHODS 
Chemicals 
All the chemicals used were of analytical grade and were purchased 
from Sigma Chemical Co. (St. Louis, USA), Merck (Mumbai, India) 
and Sisco Research Laboratories Pvt. Ltd. (Mumbai, India). Rottlerin 
was purchased from Calbiochem, Germany. 
In vitro oxidant scavenging activity  
The oxidant scavenging activity using DPPH was assayed by the 
method as stated by Shen et al., 2010 [11]. Superoxide radical 
scavenging activity was assayed by the method of Rao and 
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Kunchandy, 1990 [12]. ABTS scavenging activity was estimated by 
the method as stated by Sithisarn et al. 2005 [13]. Ascorbic acid was 
used as a control and the results were expressed as percentage 
inhibition with respect to control.  
In vitro mineralization assay 
To determine the extent of calcium phosphate (CaP) precipitation, 
homogenous mineralization system was used to study the extent of 
in vitro mineral phase formation in the absence of any matrix. The 
homogenous system consisted of 0.1 M Tris buffer (pH 7.4), 5 mM 
CaCl2 and 5 mM KH2PO4. After incubating this system at 37 °C, 
precipitates obtained were centrifuged, and the pellets were 
resuspended in 0.1N HCl. This 5 ml system for mineralization, 
already standardized in our laboratory was used to study the extent 
of in vitro mineral phase formation in the absence of any matrix [14-
15]. The calcium and phosphate ions concentration in the precipitate 
represented the extent of precipitation of these ions and the sample 
containing inhibitory biomolecule(s) minimized the extent of their 
precipitation. The percent inhibition in the mineral phase was 
calculated as % inhibition = [(C-T)/C] x 100, where C is the 
concentration of calcium and phosphate ions of the precipitate 
formed in the control system and T are the concentrations of 
calcium and phosphate ions of the precipitate formed in the test 
system, respectively. The concentration of calcium and phosphate 
ions was measured [16-17]. 
Animals and treatment schedule 
Healthy male wistar rats weighing between 150 and 200 g of 
equivalent age groups were obtained from the central animal house 
of Panjab University, Chandigarh, India. The procedures followed 
were approved by the Institutional Animal Ethics Committee and 
were in accordance with the Guidelines for Humane Use and Care of 
Laboratory Animals (PU/IAEC/S/14/41). 
To induce CaOx crystal formation, rats were exposed to 0.4 
%ethylene glycol (EG) with 1.0 % ammonium chloride (NH4Cl) in 
drinking water for 9 d. All rats were randomly divided into the 
groups having 5-7 rats each. Normal (NRM) rats were provided with 
standard animal feed and water ad libitum for 9 d. Hyperoxaluric 
group (HYO) of rats were given 0.4 % EG (v/v) with 1.0 % NH4Cl 
(w/v) in drinking water for 9 d. rottlerin treated HYR1 group was 
administered an intraperitoneal dose of 1mg/kg/day rottlerin. in 
addition to the hyperoxaluric dose of 0.4 % EG with 1.0 % NH4Cl in 
their drinking water for 9 d. ROT1 group rats were given an 
intraperitoneal dose of 1mg/kg/d rottlerin alone for 9 d. The 
standardization of the hyperoxaluric rat model was already done in 
the lab from previous studies [18]. 
Sample collection 
At the end of treatment period, rats were placed in metabolic cages, 
and urine was collected. The concentration of phosphate was 
estimated in urine [17]. Rats were anesthetized with diethyl ether 
and sacrificed by decapitation on day 10.  
Isolation of mitochondria 
The kidney was washed in normal saline at 4 °C, trimmed of adipose and 
connective tissues, weighed, and homogenized, (10 % w/v) in buffer 
containing 0.25 M sucrose, 5 mM HEPES, 1 mM EDTA, and 0.1 % bovine 
serum albumin pH 7.2. The homogenate was centrifuged at 1000x g for 5 
min to remove the nuclear fraction and cell debris. Mitochondrial pellet 
was obtained by centrifuging the post-nuclear supernatant at 14,000x g 
for 20 min. The pellet was washed thrice with 1.15 % potassium chloride 
solution and finally suspended in 0.25 M sucrose solution. The 
mitochondrial fraction was used for various assays.  
Measurement of antioxidant status 
Total thiols (T-SH) were determined in the mitochondria and 
homogenate according to the method of Sedlak [19]. The results were 
expressed as nmol T-SH/mg protein. The activity of isocitrate 
dehydrogenase (ICDH) in was determined by the method of 
Bergmeyer and Bernt [20]. The results were expressed as nanomoles 
of NADPH formed/min/mg protein. Glutathione reductase activity in 
post-mitochondrial fraction was assayed by the method of Carlberg 
and Mannervik [21]. Enzyme activity was calculated using the molar 
extinction coefficient of NADPH. The results were expressed as 
nanomoles of NADPH oxidized/min/mg protein. Glutathione-S-
transferase (GST) activity in post-mitochondrial fraction was assayed 
in the post-mitochondrial supernatant by the method of Habig et al. 
[22]. Mitochondrial ATPase activity was assayed as described by 
Griffiths and Houghton [23]. Citrate synthase (CS) was assayed by the 
method of Spinazzi et al. [24]. The results were expressed as 
nanomoles of TNB formed/min/mg protein. 
Statistical analysis 
Data were analyzed by one-way ANOVA and the Tukey’s test for 
multiple comparisons using GraphPad Prism (version 5.0; San Diego, 
USA). They are expressed as mean±SD. Results were considered 
significant if P ˂ 0.05. 
RESULTS 
In vitro antioxidant activity of rottlerin 
The in vitro antioxidant activity of rottlerin was assayed using three 
different activity assays. DPPH radical scavenging activity assay with 
respect to ascorbic acid revealed that the maximum percentage 
inhibition of DPPH radical was seen at a concentration of 40 µg (97.82 
%) and at 80 µg (56.35 %) and 100 µg (46.03 %) the inhibitory activity 
of rottlerin rapidly declined (Fig.1A). Superoxide radical inhibition of 
rottlerin was found to be highest at a concentration of 40 µg (69.29 %) 
with respect to ascorbic acid (Fig.1B). At a concentration of 60 to 100 
µg the increase in the inhibition was proportional to the increase in 
the concentration of rottlerin. ABTS radical scavenging activity was 
found to be increased with an increase in the concentration of rottlerin 
with respect to ascorbic acid (fig. 1C). 
 
 
Fig. 1: In vitro radical scavenging activity of rottlerin. A) DPPH radical scavenging activity assay B) Superoxide radical scavenging activity 
assay C) ABTS radical scavenging activity assay. The results are expressed as percentage inhibition with respect to ascorbic acid. Values 
are expressed as mean±SD of three similar experiments (n=3) 
 
Effect of rottlerin on in vitro calcium phosphate mineralization 
To evaluate the effect of rottlerin on the initial calcium phosphate 
mineral phase formation, the extent of inhibition of calcium and 
phosphate ions was measured. It was found that the maximum 
inhibition of calcium ions was at a concentration of 1 mg of rottlerin 
(49.33 %). The inhibition of calcium ions are increased with an 
increase in the concentration of rottlerin (fig. 2B). A similar trend 
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was observed in the inhibition of phosphate ions. The maximum 
inhibition was noted at a concentration of 1 mg of rottlerin (75.63 
%). The percentage inhibition observed was with respect to that of a 
control system (fig. 2B). 
 
Fig. 2: Inhibition of in vitro calcium phosphate mineral phase by 
rottlerin A) Inhibition of calcium ions B) Inhibition of 
phosphate ions. The results are expressed as percentage 
inhibition with respect to control. Values are expressed as 
mean±SD of three similar experiments (n=3) 
 
Effect of rottlerin on kidney to body weight ratio, urinary pH, 
and urinary phosphate 
Kidney to body weight ratio was found to be increased in the HYO 
rats as compared to NRM group. The rats treated with rottlerin 
showed a near control level of the ratio of the kidney to body weight. 
Urine of HYO rats showed an acidic pH as compared to the NRM 
group (fig. 3A). Rottlerin treated rats showed pH values similar to 
those of NRM rats (fig. 3B). 
 
Fig. 3: Effect of rottlerin on urinary parameters in 
hyperoxaluric rats  A) Kidney weight/Body weight B) Urinary 
pH. NRM: normal rats; HYO: hyperoxaluric rats; HYR1: 
hyperoxaluric rats treated with rottlerin 1mg/kg/d; ROT1: 
normal rats treated with rottlerin 1mg/kg/d.Values are 
expressed as Mean±SD of 5 rats per group. The results are 
compared by ANOVA with Tukey’s multiple comparison post 
hoc test; a: P<0.05 significantly different from NRM group; b: 
P<0.05 significantly different from HYO group 
 
Urine of HYO group rats showed a significant increase in the 
concentration of phosphate (63.57 %) as compared to NRM rats. 
HYR1 rats showed a significant decline in urinary phosphate as 
compared to HYO rats (table1). 
 
Table 1: Effect of rottlerin on A) Total thiols ; B) Glutathione-S-transferase;  C) Glutathione reductase;  and D) Urinary phosphate in 
hyperoxaluric rats. 
 NRM HYO HYR1 ROT1 
































NRM: normal rats; HYO: hyperoxaluric rats; HYR1: hyperoxaluric rats treated with rottlerin 1mg/kg/d; ROT1: normal rats treated with rottlerin 
1mg/kg/d.Values are expressed as Mean±SD of 5 rats per group. The results are compared by ANOVA with Tukey’s multiple comparison post hoc 
test; a: P<0.05 significantly different from NRM group; b: P<0.05 significantly different from HYO group. 
 
Effect of rottlerin on total thiols, GST, and GR  
To evaluate the effect of rottlerin on antioxidant status of HYO rats, 
the level of total thiols was estimated in mitochondrial fraction and 
post-mitochondrial supernatant. The results revealed a significant 
decline in the level of total thiols in the HYO rats in both the 
fractions. Supplementation of rottlerin led to the restoration of total 
thiols content.  
Furthermore, the activities of GST and GR significantly dwindled in the 
HYO rats. Rottlerin treatment at a dose of 1 mg/kg increased the 
activities of GST and GR by 34.50 % and 63.94 %, respectively (Table1).  
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Effect of rottlerin on activity of ATPase, isocitrate dehydrogenase, 
and citrate synthase 
Activities of ATPase, ICDH, and CS were significantly diminished in the 
HYO group.  
Rottlerin supplementation significantly restored the activities of 
ATPase and ICDH at the dose of 1mg/kg/d. However, the increase in 
activity of CS in HYR1 group was not significant as compared to the 
HYO group (fig.4 A, B, C).  
 
Fig. 4: Effect of rottlerin on A) Mitochondrial total thiols; B) ATPase; C) Isocitrate dehydrogenase; and D) Citrate synthase in hyperoxaluric 
rats. NRM: normal rats; HYO: hyperoxaluric rats; HYR1: hyperoxaluric rats treated with rottlerin 1mg/kg/d; ROT1: normal rats treated with 
rottlerin 1mg/kg/d.Values are expressed as Mean±SD of 5 rats per group. The results are compared by ANOVA with Tukey’s multiple 
comparison post hoc test; a: P<0.05 significantly different from NRM group; b: P<0.05 significantly different from HYO group. 
 
DISCUSSION 
The current treatment of urolithiasis employs the use of minimally 
invasive and non-invasive stone managements such as 
extracorporeal shock wave lithotripsy, percutaneous 
nephrolithotomy, and endoscopy for the removal of kidney stones; 
however, high recurrence rates have been reported: 10 to 23 % per 
year [25] and 50 % at 5 y [26]. The problem of stone occurrence is 
one of the major concerns in urolithiasis therapy and, therefore, 
requires an effective prophylactic regimen. Potassium citrate 
therapy is recommended as a remedy intended to stretch the stone-
free condition [27]. Kidney stone formation is a complex process and 
the result of a cascade of events, including crystal nucleation, 
growth, aggregation, and crystal retention within the renal tubules 
[28-30]. It has been proposed that oxalate-induced injury to renal 
tubular epithelial cells is caused by the production of reactive 
oxygen species. Oxidative stress influences cell injury and 
inflammatory processes that promote aggregation and retention of 
CaOx crystals [31]. Another study reported that renal tubular cell 
injury is mediated by free radical formation. High concentrations of 
oxalate, as well as CaOx crystals, are toxic to renal tubular cells [32].  
Flavonoids are semi-essential food components that are 
ubiquitously present in nature. Natural products with a source of 
flavonoids are fruits, vegetables, grains, bark, roots, stems, flowers, 
tea, and wine. Free radicals attract various inflammatory mediators, 
contributing to a general inflammatory response and tissue damage. 
Flavonoids interfere with various free radical-producing systems 
including direct radical scavenging, reduction in ischemia–
reperfusion injury by interfering with inducible nitric-oxide 
synthase activity, leukocyte immobilization during ischemia, 
inflammation conditions, and the xanthine oxidase pathway, which 
is an important oxidative injury route that is inhibited by flavonoids 
[33]. In an earlier report, the antioxidative effects of flavonoids 
(catechin) in green tea decreased oxidative injury in renal tubular 
cells and CaOx deposition in the rat kidney [34]. In vitro and in vivo 
studies have concluded that the bioflavonoid quercetin has potential 
antioxidant effects of decreasing the lipid peroxidation production 
induced by oxalate in MDCK cells [35]. Renal tubular damage is 
associated with a decline in antioxidant defense of kidney and a 
decrease in the activity of free radical scavengers [36].  
Reducing power is correlated with antioxidant activity and may 
serve as a significant reflection of the antioxidant activity. 
Compounds with reducing power indicate that they are electron 
donors and can reduce the oxidized intermediates of lipid 
peroxidation processes so that they can act as primary and 
secondary antioxidants [37]. Rottlerin is a flavonoid plant product 
isolated from the fruit covering of Mallotus Phillipinensis [4]. In-
vitro antioxidant activity assays demonstrated the antioxidant 
potential of rottlerin, which may be due to the presence of five–OH 
groups in its structure, which may act as scavengers of free radicals. 
Rottlerin effectively scavenged the DPPH, ABTS, and superoxide 
radicals when compared with respect to ascorbic acid. Furthermore, 
an in-vitro calcium phosphate mineralization system developed in 
our laboratory showed the inhibitory potential of rottlerin on the 
extent of calcium and phosphate mineralization. It is well 
documented that calcium oxalate crystals grow attached to calcium 
phosphate crystals [38]. Inhibition of calcium phosphate 
mineralization may point towards its efficacy in inhibiting calcium 
oxalate crystallization.  
Rat models of calcium oxalate urolithiasis induced by either ethylene 
glycol alone or in combination with other drugs such as ammonium 
chloride are often used to study the pathogenesis of kidney crystal 
deposition. In the light of inhibitory action on calcium phosphate 
mineralization and free radical scavenging properties, rottlerin was 
checked for its effects on a rat model of hyperoxaluria already well-
established in our laboratory [18]. The biochemical mechanisms for 
this process are related to an increase in the urinary concentration 
of oxalate. In the present study, urinary pH was significantly 
decreased in the hyperoxaluric rats. The concomitant increase in 
urinary pH with rottlerin treatment suggested an increase in urinary 
citrate excretion. Citrate reduces CaOx supersaturation by the 
formation of complexes with calcium and directly inhibits crystal 
growth and aggregation by increasing urinary pH. Intracellular pH is 
altered by a change in systemic pH, leading to changes in citrate 
reabsorption and hence urinary citrate excretion [39]. The 
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significant increase in urinary pH of hyperoxaluric rats administered 
with rottlerin suggests its possible involvement in modifying kidney 
function. The kidney to body weight ratio of hyperoxaluric rats was 
significantly increased which suggested a loss of overall body weight 
of rats; rottlerin administration restored the kidney to body weight 
ratio to control levels. There was a significant increase in urinary 
excretion of phosphate in hyperoxaluric rats which suggested that 
increased urinary phosphate excretion along with hyperoxaluria 
provides an amiable environment for calcium oxalate crystal 
deposition as calcium phosphate crystals epitaxially induce calcium 
oxalate deposition [40]. However, rottlerin treatment reduced the risk 
of crystal deposition by lowering the urinary excretion of phosphate. 
Restoration of the antioxidant defense system of cells reverses the 
oxalate and/or calcium oxalate crystal-induced renal damage and 
prevents additional crystal deposition [36]. Total thiols level was 
significantly diminished in hyperoxaluric rats as compared to the 
control groups along with a decrease in the activities of GR and GST. 
GR is crucial in maintaining the level of reduced glutathione by 
reduction of glutathione disulfide. GST is involved in detoxification 
of lipid peroxides by conjugation of reduced glutathione. As these 
enzymes are involved in the antioxidant defense of cell, the 
significant decline in the activities of these glutathione metabolizing 
enzymes suggests perturbation of oxidant/antioxidant balance in 
the renal cell milieu. The decrease in GR might be due to the 
reduction in the availability of its cofactor, NADPH [41]. 
Administration of rottlerin restored the activities and hence, 
antioxidant defense by these enzymes.  
Mitochondria are one of the major targets of hyperoxaluria-induced 
oxidative stress. Hyperoxaluric group rats exhibited a significant 
decline in the level of total mitochondrial thiols suggesting a 
dwindled reductive environment in mitochondria. Likewise, the 
activity of mitochondrial enzymes such as ATPase, ICDH as well as that 
of CS was significantly lowered in the hyperoxaluric rats. Increase in 
oxalate load might be the possible reason for the dwindling activities 
of these enzymes, as reactive oxygen species produced by 
oxalate/calcium oxalate can inactivate the mitochondrial enzymes 
[41]. Treatment with rottlerin imparted protection to mitochondria 
against oxidative damage by restoring total thiols level to near control 
levels. The activities of ATPase and ICDH, but not of CS, were 
significantly restored by rottlerin treatment.  
CONCLUSION 
Taken together, the present study has implicated that free radical 
scavenging and restoration of antioxidant defenses protect renal 
cells from renal injury. Rottlerin exhibited in vitro radical scavenging 
activity as well as in vitro inhibition of calcium phosphate 
mineralization. It may be put forward that rottlerin is effective 
against ethylene glycol induced renal cell impairment by protecting 
the antioxidant defense systems in the renal tissue. The present 
study also demonstrated the protective effect of rottlerin against 
hyperoxaluria-induced oxidative damage in mitochondria. Positive 
effects of rottlerin in combating free radical damage in the biological 
system should be evident when inspected on a long-standing basis 
as free radical damage occurs in due course. The prospect of 
surmounting this anomaly with a range of modulators is a 
productive area for future exploration. 
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